Literature DB >> 24935122

Possible fetal determinants of male infertility.

Anders Juul1, Kristian Almstrup1, Anna-Maria Andersson1, Tina K Jensen1, Niels Jørgensen1, Katharina M Main1, Ewa Rajpert-De Meyts1, Jorma Toppari1, Niels E Skakkebæk1.   

Abstract

Although common reproductive problems, such as male infertility and testicular cancer, present in adult life, strong evidence exists that these reproductive disorders might have a fetal origin. The evidence is derived not only from large epidemiological studies that show birth-cohort effects with regard to testicular cancer, levels of testosterone and semen quality, but also from histopathological observations. Many infertile men have histological signs of testicular dysgenesis, including Sertoli-cell-only tubules, immature undifferentiated Sertoli cells, microliths and Leydig cell nodules. The most severe gonadal symptoms occur in patients with disorders of sexual development (DSDs) who have genetic mutations, in whom even sex reversal of individuals with a 46,XY DSD can occur. However, patients with severe DSDs might represent only a small proportion of DSD cases, with milder forms of testicular dysgenesis potentially induced by exposure to environmental and lifestyle factors. Interestingly, maternal smoking during pregnancy has a stronger effect on spermatogenesis than a man's own smoking. Other lifestyle factors such as alcohol consumption and obesity might also have a role. However, increasing indirect evidence exists that exposure to ubiquitous endocrine disrupting chemicals, present at measurable concentrations in individuals, might affect development of human fetal testis. If confirmed, health policies to prevent male reproductive problems should not only target adult men, but also pregnant women and their children.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24935122     DOI: 10.1038/nrendo.2014.97

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   43.330


  136 in total

1.  Intrauterine exposure to mild analgesics during pregnancy and the occurrence of cryptorchidism and hypospadia in the offspring: the Generation R Study.

Authors:  Claudia A Snijder; Andreas Kortenkamp; Eric A P Steegers; Vincent W V Jaddoe; Albert Hofman; Ulla Hass; Alex Burdorf
Journal:  Hum Reprod       Date:  2012-02-02       Impact factor: 6.918

2.  Clinical and biological parameters in 166 boys, adolescents and adults with nonmosaic Klinefelter syndrome: a Copenhagen experience.

Authors:  Lise Aksglaede; Niels E Skakkebaek; Kristian Almstrup; Anders Juul
Journal:  Acta Paediatr       Date:  2011-03-28       Impact factor: 2.299

3.  Birth weight in relation to sex steroid status and body composition in young healthy male siblings.

Authors:  Griet Vanbillemont; Bruno Lapauw; Veerle Bogaert; Hélène De Naeyer; Dirk De Bacquer; Johannes Ruige; Jean-Marc Kaufman; Youri E C Taes
Journal:  J Clin Endocrinol Metab       Date:  2010-02-03       Impact factor: 5.958

4.  Association of placenta organotin concentrations with congenital cryptorchidism and reproductive hormone levels in 280 newborn boys from Denmark and Finland.

Authors:  Panu Rantakokko; Katharina M Main; Christine Wohlfart-Veje; Hannu Kiviranta; Riikka Airaksinen; Terttu Vartiainen; Niels E Skakkebæk; Jorma Toppari; Helena E Virtanen
Journal:  Hum Reprod       Date:  2013-03-21       Impact factor: 6.918

5.  Testicular cancer incidence to rise by 25% by 2025 in Europe? Model-based predictions in 40 countries using population-based registry data.

Authors:  Charlotte Le Cornet; Joannie Lortet-Tieulent; David Forman; Rémi Béranger; Aude Flechon; Béatrice Fervers; Joachim Schüz; Freddie Bray
Journal:  Eur J Cancer       Date:  2013-12-23       Impact factor: 9.162

6.  A mixture of the "antiandrogens" linuron and butyl benzyl phthalate alters sexual differentiation of the male rat in a cumulative fashion.

Authors:  A K Hotchkiss; L G Parks-Saldutti; J S Ostby; C Lambright; J Furr; J G Vandenbergh; L E Gray
Journal:  Biol Reprod       Date:  2004-07-30       Impact factor: 4.285

Review 7.  Associations among hypospadias, cryptorchidism, anogenital distance, and endocrine disruption.

Authors:  Michael H Hsieh; Benjamin N Breyer; Michael L Eisenberg; Laurence S Baskin
Journal:  Curr Urol Rep       Date:  2008-03       Impact factor: 3.092

8.  Epigenetic regulation of the RHOX homeobox gene cluster and its association with human male infertility.

Authors:  Marcy E Richardson; Andreas Bleiziffer; Frank Tüttelmann; Jörg Gromoll; Miles F Wilkinson
Journal:  Hum Mol Genet       Date:  2013-08-13       Impact factor: 6.150

9.  Dioxin exposure, from infancy through puberty, produces endocrine disruption and affects human semen quality.

Authors:  Paolo Mocarelli; Pier Mario Gerthoux; Donald G Patterson; Silvano Milani; Giuseppe Limonta; Maria Bertona; Stefano Signorini; Pierluigi Tramacere; Laura Colombo; Carla Crespi; Paolo Brambilla; Cecilia Sarto; Vittorio Carreri; Eric J Sampson; Wayman E Turner; Larry L Needham
Journal:  Environ Health Perspect       Date:  2008-01       Impact factor: 9.031

10.  Risk factors for congenital cryptorchidism in a prospective birth cohort study.

Authors:  Ida N Damgaard; Tina K Jensen; Jørgen H Petersen; Niels E Skakkebaek; Jorma Toppari; Katharina M Main
Journal:  PLoS One       Date:  2008-08-25       Impact factor: 3.240

View more
  37 in total

Review 1.  Fetal Hematopoietic Stem Cells Are the Canaries in the Coal Mine That Portend Later Life Immune Deficiency.

Authors:  Michael D Laiosa; Everett R Tate
Journal:  Endocrinology       Date:  2015-08-04       Impact factor: 4.736

Review 2.  The Epigenetic Consequences of Paternal Exposure to Environmental Contaminants and Reproductive Toxicants.

Authors:  Molly S Estill; Stephen A Krawetz
Journal:  Curr Environ Health Rep       Date:  2016-09

3.  Male reproductive disorders, diseases, and costs of exposure to endocrine-disrupting chemicals in the European Union.

Authors:  Russ Hauser; Niels E Skakkebaek; Ulla Hass; Jorma Toppari; Anders Juul; Anna Maria Andersson; Andreas Kortenkamp; Jerrold J Heindel; Leonardo Trasande
Journal:  J Clin Endocrinol Metab       Date:  2015-03-05       Impact factor: 5.958

Review 4.  Developmental origins of male subfertility: role of infection, inflammation, and environmental factors.

Authors:  Undraga Schagdarsurengin; Patrick Western; Klaus Steger; Andreas Meinhardt
Journal:  Semin Immunopathol       Date:  2016-06-17       Impact factor: 9.623

5.  Men's knowledge of their own fertility: a population-based survey examining the awareness of factors that are associated with male infertility.

Authors:  D Daumler; P Chan; K C Lo; J Takefman; P Zelkowitz
Journal:  Hum Reprod       Date:  2016-11-05       Impact factor: 6.918

6.  Male birthweight, semen quality and birth outcomes.

Authors:  B W Whitcomb; M S Bloom; S Kim; Z Chen; G M Buck Louis
Journal:  Hum Reprod       Date:  2017-03-01       Impact factor: 6.918

7.  Anogenital Distance in Healthy Infants: Method-, Age- and Sex-related Reference Ranges.

Authors:  Margit Bistrup Fischer; Marie Lindhardt Ljubicic; Casper P Hagen; Ajay Thankamony; Ken Ong; Ieuan Hughes; Tina Kold Jensen; Katharina M Main; Jørgen Holm Petersen; Alexander S Busch; Emmie N Upners; Sheela Sathyanarayana; Shanna H Swan; Anders Juul
Journal:  J Clin Endocrinol Metab       Date:  2020-09-01       Impact factor: 5.958

8.  Endothelin Receptor A Antagonism and Fetal Growth in Endothelial Nitric Oxide Synthase Gene Knockout Maternal and Fetal Mice.

Authors:  Kehuan Luo; Larry G Thaete; Mark G Neerhof
Journal:  Reprod Sci       Date:  2016-01-19       Impact factor: 3.060

Review 9.  Mate choice, sexual selection, and endocrine-disrupting chemicals.

Authors:  Andrea C Gore; Amanda M Holley; David Crews
Journal:  Horm Behav       Date:  2017-09-11       Impact factor: 3.587

Review 10.  Vascular endothelial growth factor A: just one of multiple mechanisms for sex-specific vascular development within the testis?

Authors:  Kevin M Sargent; Renee M McFee; Renata Spuri Gomes; Andrea S Cupp
Journal:  J Endocrinol       Date:  2015-10-15       Impact factor: 4.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.